The state of the research on therapeutics for Alzheimer’s and related dementias

Session time:  Tuesday, March 19, 11:00 am – 12:30 pm ET (in parallel to two other sessions, see program)

Location: Viger room (8^th floor)

Moderator: Sandra Black

Speakers: Neil Cashman, Stephen Cunnane, Tamas Fülöp

Individual talk titles:

• • PMN310: a humanized monoclonal antibody directed against Abeta oligomers that spares monomer and fibrillar molecular species / Neil Cashman
  • Ketones and brain energy rescue in Alzheimer and Parkinson disease / Stephen Cunnane
  • Alzheimer’s disease and infections: what is the contribution of microbes to the development and progression of Alzheimer’s disease / Tamas Fülöp